Ginsburg G S, Ozer J, Karathanasis S K
Department of Cardiology, Children's Hospital, Boston, Massachusetts, USA.
J Clin Invest. 1995 Jul;96(1):528-38. doi: 10.1172/JCI118065.
We have used apolipoprotein genes to investigate the signal transduction mechanisms involved in the control of intestinal specific gene expression. The human apoAI, apoCIII, and apoAIV genes are tandemly organized within a 15-kb DNA segment and are expressed predominantly in the liver and intestine. Transient transfection of various human apoAI gene plasmid constructs into human hepatoma (HepG2) and colon carcinoma (Caco-2) cells showed that apoAI gene transcription is under the control of two separate and distinct cell-specific promoters. The region between nucleotides -192 and -41 is essential for expression in HepG2 cells, whereas the region from -595 to -192 is essential for expression in Caco-2 cells. A third 0.6 kb DNA fragment in the apoCIII gene promoter region, approximately 5 kb down-stream from the human apoAI gene, enhances transcription mediated by either of these two tissue-specific apoAI promoters. In Caco-2 cells, expression of the apoAI gene and activation by the distal enhancer required the presence of a nuclear hormone receptor response element (NHRRE) located in the -214 to -192 apoAI promoter region. Overexpression of the orphan receptor hepatocyte nuclear factor 4 (HNF-4), which binds to the NHRRE, dramatically stimulates apoAI gene expression in Caco-2 cells but not in HepG2 cells. Maximal stimulation of transcription by HNF-4 in Caco-2 cells required the presence of both the intestinal specific promoter, the NHRRE, and distal enhancer elements. Transactivation by HNF-4 thus appears to result from functional synergy between the NHRRE binding HNF-4 and distal DNA elements containing intestinal-specific DNA binding activities. The apoAI gene provides a model system to define the mechanism(s) governing intestinal cell specific gene regulation and the role of nuclear hormone receptors in the establishment and regulation of enterocytic gene transcription.
我们利用载脂蛋白基因来研究参与肠道特异性基因表达调控的信号转导机制。人类载脂蛋白AI(apoAI)、载脂蛋白CIII(apoCIII)和载脂蛋白AIV(apoAIV)基因在一个15kb的DNA片段中串联排列,主要在肝脏和肠道中表达。将各种人类apoAI基因质粒构建体瞬时转染到人肝癌(HepG2)和结肠癌细胞(Caco-2)中,结果表明apoAI基因转录受两个独立且不同的细胞特异性启动子控制。核苷酸-192至-41之间的区域对于在HepG2细胞中的表达至关重要,而-595至-192区域对于在Caco-2细胞中的表达至关重要。apoCIII基因启动子区域中的第三个0.6kb DNA片段,位于人类apoAI基因下游约5kb处,可增强由这两个组织特异性apoAI启动子之一介导的转录。在Caco-2细胞中,apoAI基因的表达以及远端增强子的激活需要位于apoAI启动子区域-214至-192处的核激素受体反应元件(NHRRE)的存在。与NHRRE结合的孤儿受体肝细胞核因子4(HNF-4)的过表达,可显著刺激Caco-2细胞中apoAI基因的表达,但对HepG2细胞无此作用。HNF-4在Caco-2细胞中对转录的最大刺激需要肠道特异性启动子、NHRRE和远端增强子元件的共同存在。因此,HNF-4的反式激活似乎是由于结合NHRRE的HNF-4与含有肠道特异性DNA结合活性的远端DNA元件之间的功能协同作用所致。apoAI基因提供了一个模型系统,用于确定控制肠道细胞特异性基因调控的机制以及核激素受体在肠细胞基因转录的建立和调控中的作用。